These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7814154)
1. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Silins SL; Sculley TB Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154 [TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. Komano J; Sugiura M; Takada K J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461 [TBL] [Abstract][Full Text] [Related]
4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
5. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
8. Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Silins SL; Sculley TB Virology; 1994 Jul; 202(1):16-24. PubMed ID: 8009829 [TBL] [Abstract][Full Text] [Related]
9. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Kennedy G; Komano J; Sugden B Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034 [TBL] [Abstract][Full Text] [Related]
11. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
12. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495 [TBL] [Abstract][Full Text] [Related]
14. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A; Pfaff P; Lange W; Finke J Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686 [TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074 [TBL] [Abstract][Full Text] [Related]
16. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG; Crawford DH Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878 [TBL] [Abstract][Full Text] [Related]
17. Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene. Harada S; Yanagi K Microbiol Immunol; 1992; 36(5):479-94. PubMed ID: 1325025 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821 [TBL] [Abstract][Full Text] [Related]
19. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Van Scoy S; Watakabe I; Krainer AR; Hearing J Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796 [TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells. Leao M; Anderton E; Wade M; Meekings K; Allday MJ J Virol; 2007 Jan; 81(1):248-60. PubMed ID: 17035311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]